Lataa...
Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
BACKGROUND: Although antifibrotic drugs, including nintedanib and pirfenidone, slow the progression of idiopathic pulmonary fibrosis (IPF), there is little data about the timing of start of antifibrotic treatment in real-world clinical practice. The present study aimed to clarify the efficacy of nin...
Tallennettuna:
| Julkaisussa: | BMC Pulm Med |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8272304/ https://ncbi.nlm.nih.gov/pubmed/34246227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-021-01595-3 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|